Assistant Professor of Medicine, Massachusetts General Hospital
Hematology
Dr. Irene Kuter, MD
|
|
Give Review
Irene Kuter practices Hematology. He attended Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Doctor Irene Kuter, MD is a published doctor as well. He has 22 publications published. The latest was: Percutaneous placement of a central venous access device via an intercostal vein. Irene Kuter, MD accepts all Medicare patients.
Publications
- Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and ...
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients treated with Anthracyclines, Taxanes and Trastuzumab.
- Immunologic quantitation of the Carcinoma specific human Carcinoma antigen in clinical samples.
- Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast Cancer...
- Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic Breast carcinoma.
- Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast Cancer.
- Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast Cancers in patients treated with neoadjuvant chemotherapy: clinical implications.
- Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast Cancer.
- Flare response in 18F-fluoride ion PET bone scanning.
- Survival in patients with brain metastases from breast Cancer: the importance of HER-2 status.
- VEGF as a marker for outcome among advanced breast Cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
- Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
- Collagenase secretion accompanying changes in cell shape occurs only in the presence of a biologically active cytokine.
- Percutaneous placement of a central venous access device via an intercostal Vein.
- Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast Cancer.
- Breast Cancer highlights.
- Breast Cancer update.
- Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast Cancer.
- Risk of pneumonitis in breast Cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
- Circulating tumor cells as predictors of response and failure in breast Cancer patients treated with preoperative chemotherapy.
Schools
Harvard Medical School
Massachusetts General Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Top MD
- Super Doctor
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1629052410 | |
| NPPES Provider LastName | KUTER | |
| NPPES Provider FirstName | IRENE | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 272.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629052410 |
| Last Name Of The Provider | KUTER |
| First Name Of The Provider | IRENE |
| View All |
Similar Doctors
|
|
Dr. Shrikanta Chattopadhyay, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan D. Nipp, MD |
|
|
Dr. Craig C. Earle, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John V. Frangioni, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Russell W. Jenkins, MD |
|
|
Dr. Susan T. Schumer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirstine Y. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pallavi Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald W. Kufe, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Janet L. Abrahm, MD |
|
|
Dr. Jacalyn M. Rosenblatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth A. Bauer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rizwan Haq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles S. Fuchs, MD |
|
|
Dr. Ann S. Lacasce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Avigan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David P. Schenkein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monika E. Pilichowska-Roehling, MD
This Doctor is OpenDoctor Recommended.
|